Effects of pioglitazone and retinoic acid in a rotenone model of Parkinson's disease.
about
Pioglitazone ameliorates the phenotype of a novel Parkinson's disease mouse model by reducing neuroinflammationAnti-Oxidants in Parkinson's Disease Therapy: A Critical Point of ViewBezafibrate administration improves behavioral deficits and tau pathology in P301S miceSimvastatin and Bezafibrate ameliorate Emotional disorder Induced by High fat diet in C57BL/6 mice.Early post-treatment with 9-cis retinoic acid reduces neurodegeneration of dopaminergic neurons in a rat model of Parkinson's disease.Nuclear receptors in neurodegenerative diseases.A Feed-Forward Circuit of Endogenous PGC-1α and Estrogen Related Receptor α Regulates the Neuronal Electron Transport Chain9-Cis retinoic acid protects against methamphetamine-induced neurotoxicity in nigrostriatal dopamine neurons.Brain rust: recent discoveries on the role of oxidative stress in neurodegenerative diseases.Animal models of Parkinson's disease: a gateway to therapeutics?PPARγ and PGC-1α as therapeutic targets in Parkinson's.The ongoing pursuit of neuroprotective therapies in Parkinson disease.Morphogens and blood-brain barrier function in health and disease.Increased expression of retinoic acid-induced gene 1 in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression.Neuroprotective Effects of Filgrastim in Rotenone-Induced Parkinson's Disease in Rats: Insights into its Anti-Inflammatory, Neurotrophic, and Antiapoptotic Effects.Protective effects of curcumin against rotenone-induced rat model of Parkinson's disease: in vivo electrophysiological and behavioral study.Smoking and Parkinson disease: Evidence for gene-by-smoking interactions.
P2860
Q27301100-601C0932-550D-4899-8C19-2D6FFDA953C3Q28084254-7F1548F7-AF55-47D4-BA93-3DB76E46B6B1Q28273620-1AB63C2B-DC08-4D19-8F0C-CC3C5D40E2F4Q33725859-AA5988CE-10F5-49E3-8D93-D5708D20A4ECQ34435195-A4D37DFD-DCA2-4A97-8992-1679C5C173BBQ34580020-2CCA87F4-1E98-4C2E-B61C-C89B69651791Q36759960-EF17F6B9-5810-4E9F-8E6F-87C1AF6F7759Q37515682-D3AFCD2C-C1AD-4DAE-90C7-BE4DF2C750DAQ38009974-C385C0DD-7ED6-4880-B121-9C4052320098Q38155480-4F65EC6F-5D46-4078-BE1E-91BBED556358Q38227702-087D7070-6F96-4422-9414-D7CAF39F7C46Q38275171-8FB97ADF-928C-4820-B91A-FF734BAF064AQ38824367-9B8748E8-4FD6-4919-B72F-3E27C2A1926AQ39039315-8EA2673F-F6B1-496B-884E-9ADE347FD57CQ47868304-5CBEA1E9-18DF-4EB9-B56F-E0E7DC7C5FC9Q48201813-461F79CA-12F8-4E1A-9E48-5C6F6CDE3C24Q49911470-9AEA16C1-208A-4C86-8A63-79376057E2AE
P2860
Effects of pioglitazone and retinoic acid in a rotenone model of Parkinson's disease.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Effects of pioglitazone and retinoic acid in a rotenone model of Parkinson's disease.
@en
Effects of pioglitazone and retinoic acid in a rotenone model of Parkinson's disease.
@nl
type
label
Effects of pioglitazone and retinoic acid in a rotenone model of Parkinson's disease.
@en
Effects of pioglitazone and retinoic acid in a rotenone model of Parkinson's disease.
@nl
prefLabel
Effects of pioglitazone and retinoic acid in a rotenone model of Parkinson's disease.
@en
Effects of pioglitazone and retinoic acid in a rotenone model of Parkinson's disease.
@nl
P50
P1476
Effects of pioglitazone and retinoic acid in a rotenone model of Parkinson's disease
@en
P2093
Murat Gürsoy
Tayfun I Uzbay
P304
P356
10.1016/J.BRAINRESBULL.2011.05.001
P577
2011-05-11T00:00:00Z